Reframing the conversation: Drug discovery and AI at JPMorgan Chase Healthcare Conference

twoXAR CEO Andrew Radin participates in the AAMA Silicon Valley panel centered on “AI: The Next Digital Frontier for Healthcare Innovation”

Aria Pharmaceuticals is a preclinical-stage pharmaceutical company discovering and developing novel small molecule therapies for complex diseases.

Love podcasts or audiobooks? Learn on the go with our new app.

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store
Aria Pharmaceuticals

Aria Pharmaceuticals

Aria Pharmaceuticals is a preclinical-stage pharmaceutical company discovering and developing novel small molecule therapies for complex diseases.

More from Medium

The People Behind Wish: Employee Spotlight with Erin Brusseau

Event-Based Closed-Loop Neuromorphic Systems

Q&A with Dr. Dan Foxler, Principal Scientist @ LabGenius

READ, CHECK THEN BELIEVE